Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 9 de 9
Filtrar
Mais filtros











Intervalo de ano de publicação
1.
Nutr Hosp ; 38(6): 1263-1268, 2021 Dec 09.
Artigo em Inglês | MEDLINE | ID: mdl-34658245

RESUMO

INTRODUCTION: Background: nutritional status might vary according to different underlying illnesses such as cancer or infectious diseases, including COVID-19. In this context, data from developing countries remain scarce. Objectives: the objective of this study was to assess the nutritional status and outcomes of Mexican cancer patients diagnosed with COVID-19 at a tertiary care center. Methods: this was a retrospective study including 121 consecutive cancer patients diagnosed with COVID-19 at the National Cancer Institute, Mexico City, during four months. Results: the most frequent oncological diagnoses were gynecological (19 %) and hematological (17 %). Most patients were overweight (35 %). In the univariate analysis, ≥ 65 years, intubation, hypoalbuminemia, high creatinine, lymphopenia, nutrition-impact symptoms, and ECOG 2-4 were statistically associated with lower survival. The median survival of the cohort was 41 days. Conclusions: to our best knowledge, this is the first study of its kind performed in Mexico, and as other studies from other regions, our results might aid in identifying cancer patients most at risk for severe COVID-19, and could be potentially useful to enhance public health messaging on self-isolation and social distancing among Mexican cancer patients.


INTRODUCCIÓN: Antecedentes: el estado nutricional puede variar según las diferentes enfermedades subyacentes, como el cáncer o las enfermedades infecciosas, por ejemplo, la COVID-19. En este contexto, los datos de los países en desarrollo siguen siendo escasos. Objetivos: el objetivo de este estudio fue evaluar el estado nutricional y los resultados de pacientes mexicanos con cáncer diagnosticados de COVID-19 en un centro de atención terciaria. Métodos: se trata de un estudio retrospectivo que incluyó a 121 pacientes consecutivos con cáncer diagnosticados de COVID-19 en el Instituto Nacional del Cáncer de la Ciudad de México durante cuatro meses. Resultados: los diagnósticos oncológicos más frecuentes fueron los ginecológicos (19 %) y hematológicos (17 %). La mayoría de los pacientes tenían sobrepeso (35 %) y obesidad (31 %). En el análisis univariado, ≥ 65 años, intubación, hipoalbuminemia, creatinina alta, linfopenia, síntomas de impacto nutricional y ECOG 2-4 se asociaron estadísticamente con una menor supervivencia. La mediana de supervivencia de la cohorte fue de 41 días. Conclusiones: hasta donde sabemos, este es el primer estudio de este tipo realizado en México y, al igual que otros estudios de otras regiones, nuestros resultados podrían ayudar a identificar a los pacientes con cáncer y mayor riesgo de COVID-19 grave; también podrían ser potencialmente útiles para mejorar los mensajes de salud sobre el autoaislamiento y el distanciamiento social entre los pacientes mexicanos con cáncer.


Assuntos
COVID-19/mortalidade , Neoplasias/mortalidade , Estado Nutricional , Adulto , Fatores Etários , Idoso , Idoso de 80 Anos ou mais , Análise de Variância , COVID-19/epidemiologia , Creatinina/sangue , Feminino , Humanos , Hipoalbuminemia/epidemiologia , Intubação Intratraqueal/estatística & dados numéricos , Linfopenia/epidemiologia , Masculino , México/epidemiologia , Pessoa de Meia-Idade , Sobrepeso/epidemiologia , Estudos Retrospectivos , Adulto Jovem
2.
Rev. colomb. reumatol ; 28(2): 134-140, abr.-jun. 2021.
Artigo em Espanhol | LILACS | ID: biblio-1357259

RESUMO

RESUMEN La enfermedad por Coronavirus 2019 (COVID-19) es una pandemia inesperada que ha pro vocado un estado de emergencia y que ha generado cambios drásticos en los protocolos de atención clínica. Para su tratamiento se ha descrito el papel de algunos medicamen tos usados habitualmente en artritis reumatoide, lupus eritematoso sistémico y otras enfermedades autoinmunitarias sistémicas. Debido a ello, existe un inminente riesgo de desabastecimiento, por lo cual el objetivo de esta revisión narrativa y opinión de expertos es formular recomendaciones generales clínicas y administrativas sobre el manejo de pacien tes ambulatorios con enfermedad autoinmunitaria o inflamatoria sistémica en el contexto de la pandemia por COVID-19.


ABSTRACT Coronavirus 2019 (COVID-19) is an unexpected pandemic that has caused a state of emergency, as well as generating drastic changes in clinical care protocols. Some drugs commonly used in rheumatoid arthritis, systemic lupus erythematosus, and other systemic autoimmune diseases have been described for its treatment. Therefore, there is an imminent risk of shortages. The aim of this narrative review and expert opinion is to present general recommendations on the clinical and administrative management of outpatients with autoimmune or systemic inflammatory disease, in the context of the COVID-19 pandemic.


Assuntos
Humanos , Adulto , Doença , Pneumonia , Infecções Respiratórias , Reumatologia , COVID-19 , Ocupações em Saúde , Medicina
3.
Rev Invest Clin ; 70(3): 121-125, 2018.
Artigo em Inglês | MEDLINE | ID: mdl-29943772

RESUMO

Malnutrition and muscle wasting are common features of cancer cachexia that may interfere with the patient's response to cancer treatment, survival, and quality of life. An accurate nutritional screening at the time of diagnosis and throughout the patient's treatment fosters better control of the disease. Several screening tools have proven to be useful for this purpose. Nevertheless, nutritional evaluation is not a routine practice in this clinical setting and procedures must be standardized. Nutritional risk screening (NRS), malnutrition screening tool (MST), and patient-generated subjective global assessment (PG-SGA) are the most common screening tools, and each one possesses some benefits when screening patients for malnutrition; however, weight loss over a specific time period, dietary intake and anorexia must also be considered. The body mass index-adjusted weight loss grading system predicts survival. We recommend the application of MST or NRS, followed by PG-SGA, food intake determination, measurement of body weight, and its changes as well as body composition, biochemical nutritional markers, muscle function, and physical performance.


Assuntos
Desnutrição/diagnóstico , Neoplasias/terapia , Avaliação Nutricional , Índice de Massa Corporal , Peso Corporal , Caquexia/etiologia , Caquexia/terapia , Humanos , Desnutrição/etiologia , Programas de Rastreamento/métodos , Neoplasias/complicações , Estado Nutricional , Qualidade de Vida , Risco
4.
Autoimmun Rev ; 17(7): 709-714, 2018 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-29729452

RESUMO

Sjögren's syndrome (SS) is a chronic autoimmune disorder characterised by the clinical presence of sicca syndrome. SS compromises the dysfunction of exocrine glands due to the presence of focal, mononuclear cell infiltrates that surround the ducts and replace the secretory units. Abnormal expression of different cytokines and chemokines such as B-cell activating factor, CXC Motif Chemokine Ligand 13, interleukin 6 (IL-6), IL-22, and FMS-like tyrosine kinase 3 ligand as well as that of their corresponding receptors has been implicated in the inflammatory process. The severity of glandular infiltration has been suggested to be associated with the presence of extra-glandular systemic manifestations, contributing to a clinical spectrum of the most severe disease. This review describes several cytokines and chemokines associated with B lymphocytes expressed in the minor salivary gland, their chemical structures, and their roles in SS as possible early predictors of lymphoma development and disease progression.


Assuntos
Biomarcadores/análise , Citocinas/análise , Síndrome de Sjogren/imunologia , Síndrome de Sjogren/fisiopatologia , Animais , Linfócitos B/imunologia , Humanos , Linfoma/imunologia , Linfoma/fisiopatologia , Glândulas Salivares Menores/imunologia , Glândulas Salivares Menores/patologia
5.
Curr Rheumatol Rep ; 20(5): 23, 2018 04 02.
Artigo em Inglês | MEDLINE | ID: mdl-29611001

RESUMO

PURPOSE OF REVIEW: Eosinophilic granulomatosis with polyangiitis (EGPA) is a systemic disseminated vasculitis associated with extravascular granulomas in patients suffering from asthma and tissue eosinophilia. Current therapies to achieve remission and prevent relapse include glucocorticoids and immunosuppressants like cyclophosphamide. RECENT FINDINGS: With the right treatment, clinical prognosis is favorable, so concerted efforts have been made in recent years to find new alternatives for treating severe EGPA. Monoclonal antibodies such as omalizumab, rituximab, and mepolizumab are among these new options. This review summarizes the pathogenesis and clinical manifestations of EGPA and critically examines current and emerging therapies.


Assuntos
Síndrome de Churg-Strauss/tratamento farmacológico , Imunossupressores/uso terapêutico , Anticorpos Monoclonais Humanizados/uso terapêutico , Azatioprina/uso terapêutico , Síndrome de Churg-Strauss/diagnóstico , Síndrome de Churg-Strauss/etiologia , Ciclofosfamida/uso terapêutico , Glucocorticoides/uso terapêutico , Humanos , Omalizumab/uso terapêutico , Rituximab/uso terapêutico
6.
Rev. colomb. reumatol ; 23(1): 17-23, enero-marzo.2016. tab, graf
Artigo em Espanhol | LILACS | ID: biblio-836080

RESUMO

(AU) Introducción. La insuficiencia de vitamina D se considera una epidemia mundial. Se estima que un billón de personas a escala mundial padecen de insuficiencia de vitamina D. Según diferentes estudios el 100% de la población adulta mayor de Estados Unidos y Europa presentan esta condición, la cual se ha tratado de atribuir a la hipovitaminosis D, como factor causal de muchas patologías, entre ellas a la osteoporosis, por su rol esencial en el metabolismo del calcio y en la prevención de fracturas. Objetivo. Determinar la prevalencia de la insuficiencia de vitamina D en una población de pacientes con osteoporosis, atendidos en una clínica de alta complejidad en Colombia.Materiales y métodosEstudio retrospectivo y descriptivo que incluía pacientes atendidos en la consulta externa, en las diferentes especialidades de medicina interna, en un hospital de alta complejidad en Cali, Colombia, entre los años 2013 a 2014, con diagnóstico de osteoporosis e insuficiencia de vitamina D. Se describieron las características sociodemográficas, antecedentes médicos y resultado de niveles de vitamina D, parathormona, densitometría ósea. Se determinó la prevalencia de déficit de vitamina D en pacientes con osteoporosis.ResultadosSe incluyeron 206 pacientes con diagnóstico de osteoporosis, de los cuales 114 presentaron insuficiencia de 25-hidroxicolecalciferol, para una prevalencia de 55,3%. El promedio de niveles de vitamina D fue 22ng/ml (p=0,00), con reportes de densitometría ósea que para el momento del estudio presentaban un promedio de T score de –2,1 en columna vertebral (p=0,55) y T score de –1,7 en cuello femoral (p=0,00).ConclusionesLa insuficiencia de vitamina D se ha determinado como uno de los factores asociados con osteoporosis. En una población con osteoporosis del suroccidente colombiano, la prevalencia de la insuficiencia de vitamina D fue de 53%, más baja que la reportada en otras ciudades de Colombia


Assuntos
Humanos , Osteoporose , Osteoporose Pós-Menopausa , Prevalência , Vitamina D
7.
Rev. colomb. reumatol ; 22(2): 126-132, jun. 2015. tab, graf
Artigo em Espanhol | LILACS | ID: lil-770784

RESUMO

La arteritis de Takayasu es una vasculopatía crónica inflamatoria e idiopática de las grandesarterias, cuyas consecuencias son cambios oclusivos, estenóticos o aneurismáticos de laaorta y de sus ramas inmediatas.Se presenta el caso de una mujer de 37 anos ˜ con déficit neurológico focal y angiorresonancia,que demuestra disminución del flujo de la arteria carótida interna izquierda yadelgazamiento de la arteria cerebral izquierda con aortograma torácico y de vasos de cuelloque confirma los hallazgos y, además, demuestra estenosis de la arteria subclavia izquierda,cumpliendo los criterios clasificatorios de una arteritis de Takayasu.Se realiza una revisión de la arteritis de Takayasu, haciendo énfasis en la fisiopatología,manifestaciones clínicas, diagnóstico, tratamiento y pronóstico...


Assuntos
Humanos , Arterite , Reumatologia , Arterite de Takayasu
8.
J Basic Microbiol ; 55(2): 180-5, 2015 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-25418931

RESUMO

The simultaneous removal of sulfide and p-cresol was carried out by using a marine-denitrifying consortium collected in the coastal zone of Sonora, Mexico. Different experimental conditions were used to evaluate the capacity of the consortium to simultaneously eliminate nitrate, sulfide, and p-cresol. For instance, the first set of assays was conducted at different sulfide concentrations (20, 50, and 100 mg S(2À) L(À1) ), with a fixed concentration of p-cresol (45 mg C L(À1) ). The second set of assays was developed at different concentrations of p-cresol (45, 75, and 100 mg C L(-1) ), in the presence of 20 mg S(2À) L(À1) . In all cases, the concentration of nitrate was stoichiometrically added for the complete oxidization of the substrates. The results showed removal efficiencies up to 92% for p-cresol and nitrate at 20 and 50 mg S(2À) L(À1) ; whereas at 100 mg S(2À) L(À1) removal efficiencies were 77% and 59% for p-cresol and nitrate, respectively. On the other hand, sulfide (20 mg L(À1) ) was completely removed under different concentrations of p-cresol tested, with a partial accumulation of nitrite according to the increment of p-cresol concentration. The results obtained indicate that the marine consortium was able to simultaneously remove the pollutants studied.


Assuntos
Cresóis/metabolismo , Desnitrificação , Sedimentos Geológicos/microbiologia , Consórcios Microbianos/fisiologia , Nitratos/metabolismo , Sulfetos/metabolismo , Poluentes Químicos da Água/metabolismo , Biodegradação Ambiental , México , Nitrato Redutase/metabolismo , Nitritos/metabolismo , Nitrogênio/metabolismo , Oxirredução
9.
Nutr Hosp ; 30(4): 891-5, 2014 Oct 01.
Artigo em Espanhol | MEDLINE | ID: mdl-25335678

RESUMO

BACKGROUND: Anorexia-cachexia is a frequent syndrome among cancer patients, specially in late stages: the global prevalence of para-neoplastic anorexia-cachexia ranges between 20-40% in the diagnostic stage and between 70-80% in the late stage of the disease. The co-existence of functional or structural digestive abnormalities is frequently observed among cancer patients; this is a consequence of the tumor growth and of those systemic phenomena related to metabolism, which are affected by the relationship tumor-host specific to anorexia- cachexia. OBJECTIVE: This study aimed at establishing the frequency of anorexia-cachexia, as well as its relationship to GI symptoms in the context of palliative care patients at the Instituto Nacional de Cancerología, México City. METHODS AND MATERIAL: Analytic cross-sectional study including 100 patients diagnosed with late-stage cancer, age range 18-80, and a Karnofsky score > 50, as well as an ECOG <2; patients with a bad general health status were not allowed in the study. After reviewing inclusion and exclusion criteria, participants fulfilled the FAACT questionnaire, as well as the EGS. Patients recruitment was carried out by the Instituto Nacional de Cancerología. Results and discussion: Results show that 61% (n=61)of the patients had anorexia-cachexia, and 39% (n=39)did not. 56% of the sample participants (n=34) were women, and 44% (n=27) were men. GI symptoms associated with anorexia-cachexia were: nausea (p= 0.0001), vomiting (p=0.004), early satiety (p=0.0005), dysgeusia(p=0.0005) and dysphagia (p=0.001). CONCLUSION: Anorexia and cachexia are among the most devastating and frequent symptoms in late-stage cancer patients and they are also associated with GI symptoms affecting the physical, psychosocial and existential aspects of the patient's life. Data from this research validate the importance of an early nutrition support in palliative patients so that they can achieve a better quality of life.


Introducción: La anorexia-caquexia es un síndrome frecuente en pacientes oncológicos, particularmente en etapas avanzadas: la prevalencia global de anorexia-caquexia para-neoplásica oscila entre el 20-40% en los enfermos en la fase diagnóstica, y entre el 70­80% en la fase avanzada de la enfermedad. En los enfermos oncológicos es frecuente la coexistencia de alteraciones digestivas estructurales o funcionales, secundarias al crecimiento tumoral y a los fenómenos sistémicos de carácter metabólico, determinados por la interrelación tumor-huésped específicos de la anorexia-caquexia. Objetivo: El objetivo de este trabajo es conocer la frecuencia de anorexia-caquexia, y su asociación con síntomas gastrointestinales en pacientes en terreno paliativo del Instituto Nacional de Cancerología, Ciudad de México, atendidos en el servicio de Cuidados Paliativos. Material y métodos: Se realizó un estudio transversal analítico. Se incluyeron 100 pacientes con diagnóstico de cáncer avanzado, con un rango de edad de 18 y 80 años, y una puntuación de Karnofsky > 50, así como un ECOG.


Assuntos
Anorexia/complicações , Anorexia/epidemiologia , Caquexia/complicações , Caquexia/epidemiologia , Gastroenteropatias/complicações , Gastroenteropatias/epidemiologia , Neoplasias/complicações , Academias e Institutos , Estudos Transversais , Feminino , Humanos , Masculino , México , Pessoa de Meia-Idade , Cuidados Paliativos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA